COVID-19 VACCINES UPDATE: ADDITIONAL DOSE & BOOSTER SHOTS

Vaccines remain to be the safest and most effective way to protect ourselves against and the spread of COVID-19.

Choose the best options for your own protection and the protection of others.

Additional Dose and Booster Shot
Category Additional Dose Booster Shot
Intended Population Additional doses provide additional protection for those with immunocompromised conditions. Booster shots are optional for eligible individuals and serve as reminders that our bodies need protection.
Eligibility Requirements

Those ages 12+ with immunocompromised conditions:

  • Received treatment for organ transplant or active cancer treatment and taking medications/treatments to suppress the immune system
  • Moderate or severe primary immunodeficiency
  • Advanced or untreated HIV infection
  • Actively taking medications/drugs that may suppress your immune response

For individuals who are fully vaccinated with Moderna, Pfizer-BioNTech, or Johnson & Johnson (Janssen):

A booster dose is recommended if you are age 18 or older

Available Vaccines
  • Pfizer-BioNTech (Also referred to as “Cormirnaty”)
  • Moderna
  • Pfizer-BioNTech (Cormirnaty)
  • Moderna
  • Johnson & Johnson (Janssen)
Waiting Time Any time 4 weeks after second dose
Pfizer-BioNTech (Cormirnaty) or Moderna:
Any time 6 months after second dose
Johnson & Johnson (Janssen):
Any time 2 months after the first dose
Mixing & Matching? Mixing and matching of mRNA vaccines are allowed if the vaccine manufacturer was unknown for either of the first two doses. Mixing and matching of different vaccines are allowed.

Immigrant Refugee Coalition
Fresno State Central Valley Health Policy Institute
COVID-19 Equity Project (CEP)

Information as of November 23, 2021

Source: Centers for Disease Control & Prevention

For more information, please visit the CDC COVID-19 resource page at:
https://www.cdc.gov/vaccines/covid-19/index.html

Download the PDF

This HTML version was generated with AI assistance and may contain errors or omissions. The original approved PDF remains the official document of record. An alternative accessible format is available upon request from the document creator in accordance with Title II of the ADA.